ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.
Lazar Vujanovic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.